RetaMaps

Enliven You Aesthetics and Wellness

Enliven You Aesthetics and Wellness · 13846 Dallas Parkway · Dallas, TX 75240

5.0· 74 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

Enliven You Aesthetics and Wellness is a medical aesthetics practice in Dallas, Texas. Its website describes a less-is-more philosophy built around subtle, tailored enhancements, and introduces Cinthia, who has more than a decade of nursing experience, including time as a clinical supervisor, and began working as an injector in 2021. The listing also shows weight-loss care, hormone therapy and IV therapy. On Google the practice has a 5.0-star rating across 74 reviews dating back to 2024, six of them in the past year, with reviewers most often mentioning the providers' knowledge and their results.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 5.0
Google rating · 74 reviews
6
reviews in the past year (avg ★ 5.0)
1
reviews mention GLP-1 medications

Counts computed by RetaMaps from public Google reviews; most recent review 2026-05-28. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★5.0 across 74 Google reviews. Of the 25 reviews we analyzed, 25 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).

What patients like

  • Knowledgeable, professional providers10 reviews
  • Weight-loss results7 reviews
  • Friendly, helpful staff6 reviews
  • Clean, comfortable office5 reviews

Common complaints

No negative reviews among those we analyzed.

5★
25
4★
0
3★
0
2★
0
1★
0

Most recent Google reviews

L S.★★★★★2026-05-28

5 stars for Cinthia! She is incredibly knowledgeable, professional, and genuinely cares about her clients. From the moment you walk in, she makes you feel comfortable and taken care of. I absolutely love my results every time and appreciate how natural and refreshed everything looks. Her attention to detail and honesty truly set her apart. I would highly recommend Cinthia to anyone looking for someone they can trust with their aesthetic services!

Brenda R.★★★★★2026-04-16

I’m actually obsessed 😍Cinthia was sooo amazing from start to finish. She made me feel super comfortable, explained everything, and didn’t rush me at all. 10/10 service, definitely going back to her ❤️💫

Brandon C.★★★★★2026-01-28

My wife left beyond happy! Thank you so much for everything 🙏🏽

Hartley W.★★★★★2026-01-08

On of the best IV ever, love Cinthia she is the sweetest person ever. Love it soooo much!! 💗

Haven★★★★★2026-01-02

I came in for an IV treatment, and from the consultation to the entire process, everything felt very comfortable and well taken care of. I wasn’t feeling my best, so I decided to do IV therapy along with an NAD+ injection, and afterward my body genuinely felt lighter and more refreshed. The facility was clean, and overall it’s a place I can trust and feel comfortable coming back to. I’ll definitely be visiting again I love it!! 🥰

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Dallas

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs